Clinical Trials Update:&nbsp;Dec. 13, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
511748
Northfield announces clinical trial results that investors can learn from.
414089
A website goes the extra mile to make sure voters aren & rsquo;t confused this Tuesday.  Also: West Virginia organizes the first public supercomputer & hellip;.  FDA keeps its eye on a new pain relief drug & hellip;. and more.
283297
Researchers at Merck can use neural stem-cell tech in early stages of drug development. Plus: Pay for eggs OK in Britain. In Bodyhack.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
303689
Acorda announces positive clinical trial data.
37828
A clinical trial of the blockbuster arthritis drug Celebrex was shut down yesterday after researchers found an increase in the risk of serious heart disease and strokes in those taking the
25097
The risk of treatment-related (toxic) death for cancer patients enrolled in phase 1 clinical trials had decreased significantly over the past 12 years (from 1991 to 2002), according to an article in the November 3 issue of JAMA.
415778
NEW YORK, December 24  - The Food &amp; Drug Administration (FDA) announced yesterday that it planned to examine the various studies that link the usage of several painkillers with heightened cardiovascular risks, while recommending that
466191
roundup Plus: .Mac customers suffer e-mail glitches...Alvarion expands wireless broadband in China...IBM launches business research group.
641201
A preview of some of the biopharmas presenting at the American Society of Clinical Oncology conference.
643185
FRIDAY, Sept. 15 (HealthDay News) -- Researchers may be able to determine the effectiveness of anti-angiogenic cancer drugs by measuring levels of a type of blood cell.
39223
SAN DIEGO - Two different novel targeted therapies can produce strong responses in patients who have become resistant to Gleevec(tm), the standard therapy for chronic myeloid leukemia (CML), researchers at The University of Texas MD Anderson Cancer Center
266395
New publications, experiments and breakthroughs in biotechnology--and what they mean.
240625
Pfizer Inc. said on Monday it plans to sponsor a major clinical study to further assess the cardiovascular safety of its arthritis drug Celebrex following the withdrawal of Merck & Co.'s Vioxx, a drug in the same class.
380219
New board will focus on safety of drugs already on the market. Also: Flarion makes bold moves to spur expansion of infrastructure for its mobile data technology.... Texas Instruments can make cheaper 3G phones.... and more.
409638
Promising trials for a hepatitis C treatment bode well for the pharmaceutical.